ENCINO, Calif. and CLEVELAND, Ohio, March 3, 2016 /PRNewswire/ -- Industry partners, Research Solutions, Inc. (OTCQB: RSSS), a pioneer in providing on-demand access to scientific, technical and medical (STM) information for research-intensive companies and organizations, and The Research Investment (TRI), a leading provider of research retrieval services, have completed the transition of TRI's article delivery customers onto the Article Galaxy™ platform operated by Reprints Desk®, a wholly owned Research Solutions subsidiary.
As a cloud-based software-as-a-service solution, Article Galaxy provides one-stop shopping and lowest cost acquisition of full-text journal articles from publishers without requiring the use of credit cards for each transaction. This top-ranked article delivery platform has now been further enhanced with the integration of TRI's research capabilities to source the most difficult-to-find documents.
The TRI customers acquired by Reprints Desk comprise several Fortune 500 companies, including two of the Fortune 10. They increase Reprints Desk's market penetration of the energy and chemicals sectors, and complement the company's greater than 70 percent penetration of the world's top 25 pharma companies.
"The deepening of our relationship with Reprints Desk reflects our commitment to providing the highest quality document delivery service to our valued clients, many of whom we've served for over 20 years," said TRI Founder and president, Kate Vranich. "Article Galaxy combines unmatched technical capabilities with a multitude of publisher agreements, allowing for easy and fast delivery at fair pricing. Reprints Desk is the clear choice for any research-focused team or organization."
Peter Derycz, President and CEO at Reprints Desk, commented: "While these new customers from TRI will benefit tremendously from Article Galaxy's search integration and instant delivery, they will continue to have the ability to source, when needed, the most hard-to-find documents from around the globe. Our value proposition to our existing and prospective customers has been strengthened accordingly, making our offering even more of a one-stop-shop for all of their research needs."
TRI has been in the document delivery business since the early 1970s, and was among the first to provide full-text journal articles and other content required by engineers, scientists and medical researchers. TRI will continue to focus on custom research projects while partnering with Reprints Desk to deliver difficult-to-find specialty document requests.
About The Research Investment
The Research Investment (TRI) is a marketing and business research firm. Founded over 30 years ago, TRI continues to provide insightful, proprietary studies for industries including engineering, biomedical, pharmaceutical and health sciences, chemistry and physical sciences, agricultural and life sciences, business, and law. Using primary and secondary research methodologies, TRI provides tailored specific research that meets our client's specific needs. For more information about The Research Investment please visit www.researchinvest.com.
About Research Solutions
Operating through its wholly owned subsidiary, Reprints Desk®, Inc., Research Solutions, Inc. (OTCQB:RSSS) is a pioneer in providing on-demand access to scientific, technical, and medical (STM) information to life science companies, academic institutions and other research intensive organizations. More than 70 percent of the top 25 pharmaceutical companies in the world rely on services powered by Research Solutions. Article Galaxy™, the company's cloud-based software-as-a-service (SaaS) solution, gives customers access to over one million newly published articles each year in addition to tens of millions of articles previously published, helping them to create and speed discoveries, save time and money, and remain copyright-compliant. Research Solutions has arrangements with numerous STM content publishers that allow electronic access and distribution of their content. In addition to serving end users of content, the company also serves STM publishers by facilitating compliance with applicable copyright laws. For more information about Research Solutions, visit www.researchsolutions.com.
About Reprints Desk®
Reprints Desk improves how journal articles and clinical reprints are accessed, procured, and legally used in evidence-based promotions, medical affairs, and scientific, technical, and medical (STM) research. Organizations fueled by intellectual property choose Reprints Desk because of its collaborative business approach, efficient article supply system and services, and commitment to quality post-sales support. Reprints Desk has ranked #1 in every Document Delivery Vendor Scorecard from industry analyst and advisory firm Outsell Inc. since 2008. For more information about Reprints Desk, visit www.reprintsdesk.com.
Important Cautions Regarding Forward-Looking Statements
This release contains "forward-looking statements" that include information relating to future events and future financial and operating performance. Forward-looking statements should not be read as a guarantee of future performance or results, and will not necessarily be accurate indications of the times at, or by, which that performance or those results will be achieved. Forward-looking statements are based on information available at the time they are made and/or management's good faith belief as of that time with respect to future events, and are subject to risks and uncertainties that could cause actual performance or results to differ materially from those expressed in or suggested by the forward-looking statements. Important factors that could cause these differences include, but are not limited to: changes in economic conditions; general competitive factors; acceptance of the Company's products in the market; the Company's success in obtaining new customers; the Company's success in technology and product development; the Company's ability to execute its business model and strategic plans; the Company's success in integrating acquired entities and assets, and all the risks and related information described from time to time in the Company's filings with the Securities and Exchange Commission ("SEC"), including the financial statements and related information contained in the Company's Annual Report on Form 10-K and interim Quarterly Reports on Form 10-Q. Examples of such forward looking statements in this release include statements regarding the Company's success in integrating acquired assets and the expected continued market acceptance of the Article Galaxy platform. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise. For more information, please contact:
Ian Palmer, Chief Sales and Marketing Officer
Research Solutions, Inc. and Reprints Desk, Inc.
+1 (415) 533-8308
Investor Relations for Research Solutions:
Ron Both, Senior Managing Director
Liolios Group, Inc.
+1 (949) 574-3860 ext. 1708
Sandy Covitch, Executive Vice President
The Research Investment, Inc.
SOURCE Reprints Desk, Inc.